NSC-59984

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameNSC-59984
Drug Alias NameNSC-59984
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFox Chase Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesFox Chase Cancer Center
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A